LSL PHARMA GROUP REPORTS FOURTH CONSECUTIVE RECORD QUARTERLY REVENUES AND Q3 2025 FINANCIAL RESULTS
LSL Pharma Group reports continued record revenues and strategic progress, highlighting acquisitions and regulatory milestones as part of its Q3 2025 results and Year-to-date performance. LSL Pha…